SCM
ESPR icon

Sio Capital Management’s Esperion Therapeutics ESPR Stock Holding History

Sio Capital Management’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-61,600
Closed -$2.29M – 97
2020
Q3 		$2.29M Hold
61,600
– – 0.45% 55
2020
Q2 		$3.16M Sell
61,600
-19,000
-24% -$795K 0.92% 39
2020
Q1 		$2.54M Buy
80,600
+23,942
+42% +$1.26M 0.85% 31
2019
Q4 		$3.38M Buy
+56,658
New +$2.55M 0.8% 31
2015
Q1 		– Sell
-53,600
Closed -$2.17M – 34
2014
Q4 		$2.17M Buy
+53,600
New +$1.64M 1.7% 19

Other funds holding ESPR

BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Sio Capital Management's ESPR Position: Q4 2020 in Review

Sio Capital Management sold out of Esperion Therapeutics (ESPR) in Q4 2020, closing a stake of 61,600 shares — an estimated $2.29M sold.

Sio Capital Management first reported a position in ESPR in Q4 2014 and held it in 5 quarters. The position peaked at $3.38M in Q4 2019. 158 funds tracked by Wall St. Rank hold ESPR as of Q4 2020.

  • Sio Capital Management reported no remaining Esperion Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Sio Capital Management sold 61,600 Esperion Therapeutics shares in Q4 2020, an estimated $2.29M.
  • Sio Capital Management first reported a position in Esperion Therapeutics in Q4 2014 and held it in 5 quarters.
  • Sio Capital Management's Esperion Therapeutics position peaked at $3.38M in Q4 2019.
  • 158 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q4 2020.

Based on Sio Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.